The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
The pharmacokinetics after oral administration of 1,200 mg antipyrine and intravenous administration of 0.5 mg/kg indocyanine green have been investigated in 6 normal subjects and in 20 patients with chronic liver disease of varying etiology. Severe impairment of liver function associated with a decrease in serum albumin, elevation in serum bilirubin, or prolongation in prothrombin time correlated with a fall in the clearance of both drugs. The clearance of the two drugs correlated well in normal subjects and in patients with chronic liver disease. The presence of a surgical portacaval anastomosis was associated with a lower indocyanine green clearance for comparable clearance of antipyrine. The concept of functioning hepatic parenchymal mass is proposed as a common rate-limiting parameter for the elimination of the two drugs.
D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000378:metabolism*; D001663:Bilirubin / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006207:Half-Life; D006801:Humans; D007208:Indocyanine Green / Q000378:metabolism*; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011517:Prothrombin Time; D012709:Serum Albumin / Q000378:metabolism
D012709:Serum Albumin; D007208:Indocyanine Green; D001663:Bilirubin; D000983:Antipyrine